STOCK TITAN
  1. Home
  2. Sec-filings
  3. DORM
  4. [Form 4] Dorman Products, Inc. Insider Trading Activity

Dorman Products (DORM) director awarded 1,344 restricted stock units in Form 4 filing

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Stakias G. Michael reported acquisition or exercise transactions in this Form 4 filing.

Dorman Products director G. Michael Stakias received an equity award rather than buying shares on the market. He was granted 1,344 restricted stock units representing a contingent right to receive an equal number of Dorman common shares at a reference price of $122.71 per share. The units vest in full on the earlier of the first anniversary of the grant date or the company’s next annual meeting of shareholders. Following this award, he beneficially owns 16,150 shares of common stock directly.

Positive

  • None.

Negative

  • None.

Insights

Director received routine stock-based compensation through restricted stock units.

The filing shows director G. Michael Stakias acquired 1,344 restricted stock units, a form of stock-based compensation rather than an open-market purchase. These units represent a contingent right to receive Dorman common shares at a reference value of $122.71 per share.

The units vest in full on the earlier of the first anniversary of the grant date or the company’s next annual meeting of shareholders, aligning the director’s interests with shareholders over that period. After this grant, he holds 16,150 shares directly, indicating the transaction is modest relative to his overall stake.

Insider Stakias G. Michael
Role null
Type Security Shares Price Value
Grant/Award Common Stock 1,344 $122.71 $165K
Holdings After Transaction: Common Stock — 16,150 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Restricted stock units granted 1,344 units Grant to director G. Michael Stakias
Grant reference price $122.71 per share Value used for the RSU grant
Shares owned after grant 16,150 shares Director’s direct holdings following the transaction
restricted stock units financial
"Grant of restricted stock units representing a contingent right to receive shares of Dorman common stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
contingent right financial
"representing a contingent right to receive shares of Dorman common stock."
annual meeting of shareholders regulatory
"on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders."
A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.
Form 4 regulatory
"IMPORTANT: The footnotes above are CRITICAL for accurate interpretation. They may indicate:"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Stakias G. Michael
(Last)(First)(Middle)
C/O DORMAN PRODUCTS INC.
3400 EAST WALNUT STREET
(Street)
COLMAR PENNSYLVANIA 18915
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Dorman Products, Inc. [ DORM ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/01/2026A1,344(1)A$122.7116,150D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Grant of restricted stock units representing a contingent right to receive shares of Dorman common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders.
Remarks:
The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.
/s/ Frank J. Mahr, by Power of Attorney06/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Dorman Products (DORM) director G. Michael Stakias receive in this Form 4 filing?

He received 1,344 restricted stock units as equity compensation, not an open-market stock purchase. Each unit represents a contingent right to one Dorman common share, aligning his incentives with shareholders over the vesting period described in the filing.

At what value were the restricted stock units for Dorman Products (DORM) recorded?

The 1,344 restricted stock units were recorded at a reference value of $122.71 per share. This value reflects the grant price used for reporting purposes and helps quantify the size of the director’s stock-based compensation award in the Form 4.

When do the Dorman Products (DORM) restricted stock units granted to the director vest?

The restricted stock units fully vest on the earlier of the first anniversary of the grant date or the date of Dorman’s next annual meeting of shareholders. This time-based vesting schedule encourages continued service and ties compensation to the company’s governance cycle.

How many Dorman Products (DORM) shares does the director hold after this transaction?

After the grant, G. Michael Stakias beneficially owns 16,150 shares of Dorman common stock directly. This total includes the impact of the reported award and provides context for the size of the equity grant relative to his overall direct holdings.

Is the Dorman Products (DORM) Form 4 transaction a market buy or routine compensation?

The transaction reflects routine stock-based compensation, not an open-market stock purchase. Code "A" in the Form 4 and the footnote explain it is a grant of restricted stock units, providing a contingent right to receive Dorman common shares upon vesting.